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A functional Nef protein is crucial in vivo for viral replication leading to pathogenesis in SIV-infected macaques. Moreover,
a full-length Nef protein is required for optimal virus replication in primary cells, and both HIV and SIV Nef proteins enhance
virion infectivity. Enhanced infectivity may result in part from the ability of Nef to incorporate cellular kinases into virions. In
two previous reports, we compared in vitro kinase profiles of SIV recombinant clones that express nef genes derived either
from the prototypic lymphocyte-tropic SIVmac239, clone SIV/Fr-2, or from our neurovirulent clone SIV/17E-Fr. While the
SIV/Fr-2 Nef protein associated with the previously described PAK-related kinase and an unidentified serine kinase present
in a Nef-associated kinase complex (NAKC), SIV/17E-Fr Nef was found to associate with a novel serine kinase activity that
was biochemically distinct from both PAK and NAKC. Interestingly, while both Nef proteins were incorporated into virus
particles, Nef-associated kinase activity was detected only in virions containing the SIV/17E-Fr Nef protein. Because
sequence analysis identified only five amino acids that differed between the Nef proteins of SIV/Fr-2 and SIV/17E-Fr, we were
able to evaluate the contribution of each amino acid to Nef-associated kinase activity as well as virus infectivity by
constructing a panel of SIV clones containing individual reversions of each differing amino acid in SIV/17E-Fr Nef to the
corresponding amino acid in SIV/Fr-2 Nef. In this report, we identify previously uncharacterized amino acids in the N terminus
and the conserved core domain of Nef that are essential for the detection of Nef/kinase interactions as well as Nef
phosphorylation during SIV infection. Further, via a novel infectivity assay recently developed in our laboratory that utilizes
CEMX174 reporter cells stably expressing an SIV/LTR-luciferase construct, we find no direct correlation between specific Nef
kinase associations and enhanced virion infectivity. © 2000 Academic PressINTRODUCTION
Although the importance of Nef to viral pathogenesis
has been established definitively in vivo in the macaque
model of AIDS (Kestler et al., 1991), the critical function(s)
of Nef that is interchangeable between HIV and SIV
(Alexander et al., 1999; Kirchhoff et al., 1999; Mandell et
al., 1999; Sinclair et al., 1997) is still under investigation.
Nef is not required for viral replication in vitro, although
intriguingly, cis-expression of a dominant negative form
of Nef has been shown to inhibit replication of infectious
molecular clones as well as clinical isolates (D’Aloja et
al., 1998; Olivetta et al., 2000). In infected cells, Nef is
found associated with membranes, in the cytoplasm and
in the nucleus (Franchini et al., 1986; Guy et al., 1987;
Kaminchik et al., 1991, 1994; Kienzle et al., 1992; Ranki et
al., 1994; Yu and Felsted, 1992), which suggests that the
ability to target different intracellular locations may be
important for the complete and apparently versatile func-
tion of Nef (Baur et al., 1994).
Indeed, several functions of Nef have been described,
1 These authors contributed equally to this work.
2 To whom reprint requests should be addressed. Fax: (410) 955-
9823. E-mail: jclement@jhmi.edu.
329notably downregulation of CD4 and MHC I from the
surface of infected cells (reviewed in Piguet et al., 1999).
Although these functions of Nef have been well charac-
terized in vitro, their relative contributions to viral patho-
genesis in vivo have been suggested (Asamitsu et al.,
1999; Carl et al., 1999a,b, 2000a,b) but not yet estab-
lished. Nef also enhances virion infectivity (Flaherty et
al., 1997a; Miller et al., 1994) at a postentry event pre-
ceding reverse transcription in target cells (Aiken and
Trono, 1995; Schwartz et al., 1995), strongly suggesting
that optimal infectivity is mediated by virion-incorporated
Nef (Pandori et al., 1996; Welker et al., 1996), the majority
of which is associated with the mature core (Kotov et al.,
1999). We have previously shown that SIV Nef is also
incorporated into virions (Flaherty et al., 1997a), but un-
like HIV-1 Nef, SIV Nef is not cleaved by the viral pro-
tease, an observation functionally consistent with the
finding that SIV Nef can enhance the infectivity of nef-
defective HIV-1 (Chen et al., 1998), indicating that the
ability of Nef to be cleaved by the viral protease does not
correlate with increased infectivity. As such, the possi-
bility exists that Nef facilitates virion incorporation of a
cellular protein (perhaps activated by the viral protease)
that potentiates infectivity.
In this regard, Nef has been shown to associate with
0042-6822/00 $35.00
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330 BARBER ET AL.several cellular proteins in a variety of expression sys-
tems and cell types. The ability of Nef to associate, in
particular, with a p21-activated protein kinase (PAK)-re-
lated kinase (Nunn and Marsh, 1996; Sawai et al., 1994),
ecently identified as PAK-1 (Fackler et al., 2000) or PAK-2
Renkema et al., 1999), depending on the Nef protein
nvestigated, and an unidentified serine kinase present
n a Nef-associated kinase complex (NAKC) (Baur et al.,
997) may correlate with enhanced virion infectivity and
roviral DNA synthesis in some cell types (Baur et al.,
997; Luo and Garcia, 1996; Wiskerchen and Cheng-
ayer, 1996). The relevance of these “in vitro Nef-asso-
iated kinases” to disease progression in vivo is under
nvestigation, but reported data are controversial (Al-
rovandi et al., 1998; Carl et al., 2000b; Khan et al., 1998;
ang et al., 1997; Sawai et al., 1996, 2000).
Several potential sites for phosphorylation also exist in
ef that may regulate Nef function (Bandres et al., 1994;
uo et al., 1997a), and a number of reports either confirm
hat Nef is phosphorylated during infection (Barber et al.,
998) or demonstrate that Nef can be phosphorylated in
itro by cellular kinases such as lck, PKC, and a serine
inase present in NAKC (Bodeus et al., 1995; Coates et
l., 1997; Coates and Harries, 1995; Collette et al., 1995;
uy et al., 1990; Luo et al., 1997a). Although the con-
erved PKC site appears to be important for SIV replica-
ion in rhesus macaques (Carl et al., 1999a), the contri-
ution of phosphorylation to Nef function is unknown.
In vivo studies of SIV have documented that extensive
utations occur upon inoculation of rhesus macaques
hat alter the amino acid sequence of Nef (Flaherty et al.,
997b; McArthur, 1987; Sawai et al., 2000; Whatmore et
l., 1995), which suggests that accumulated mutations
ay enable the virus to adapt to rapid changes in intra-
ellular environments, perhaps potentiating productive
irus replication in diverse cell types and tissues, includ-
ng the central nervous system (CNS). To explore this
ossibility, we first compared in vitro kinase activities
ssociated with Nef proteins derived either from SIV/Fr-2
r from our neurovirulent, molecular clone, SIV/17E-Fr.
IV/Fr-2 is identical to SIV/17E-Fr except that SIV/Fr-2 nef
FIG. 1. Alignment of amino acid sequeas been replaced with SIVmac239 nef (Flaherty et al.,
997b). The results of our studies indicate that SIV/17E-Fr
a
rauses neurological disease in vivo (Mankowski et al.,
997) despite the fact that the Nef protein of this virus
oes not activate the PAK-related kinase in vitro (Barber
t al., 1998), strongly suggesting that interaction with PAK
s not required for virus replication or disease induction
n the CNS. Further, we have demonstrated that SIV/
7E-Fr Nef associates with a novel serine kinase that
hosphorylates Nef itself (Barber et al., 1998) and is
ncorporated into SIV/17E-Fr virions (Flaherty et al.,
997a), potentially playing a pivotal role in virion infec-
ivity. Because there are five amino acid differences be-
ween the Nef proteins of SIV/Fr-2 and SIV/17E-Fr (Fla-
erty et al., 1997b), we examined the contribution of
pecific amino acids to Nef-associated kinase activity by
onstructing a panel of clones containing reciprocal re-
ersions of SIV/17E-Fr Nef amino acids to the corre-
ponding SIV/Fr-2 Nef residues. We report that differen-
ial kinase associations/activation map to previously un-
haracterized amino acids at the N terminus and central
ore region of SIV Nef. Further, we demonstrate that the
ssential determinants of Nef-mediated enhancement of
iral infectivity are independent of the ability of Nef to
ssociate with any of these cellular kinases.
RESULTS
reviously uncharacterized amino acids in Nef
ediate interactions with different kinases
We have previously reported distinct in vitro kinase
ssay profiles exhibited by the molecular clones SIV/
7E-Fr and SIV/Fr-2. SIV/17E-Fr, a neurovirulent clone,
ssociates with a novel serine/threonine kinase activity
hat is incorporated into the virus particle and results in
he phosphorylation of Nef itself (Barber et al., 1998;
laherty et al., 1997a). SIV/Fr-2 is identical to SIV/17E-Fr
xcept that it contains the SIVmac239 nef open gene
esulting in five amino acid differences between the two
ef proteins (Fig. 1). The Nef protein of SIV/Fr-2, like
IVmac239 Nef, interacts with a PAK-related kinase (Nunn
nd Marsh, 1996; Sawai et al., 1994) and a serine kinase
n a Nef-associated kinase complex (NAKC) (Barber et
SIV/17E-Fr and SIV/Fr-2 Nef proteins.l., 1998; Baur et al., 1997). A panel of clones containing
eversions of each amino acid in 17E-Fr Nef to the Fr-2
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331TWO SIV NEF AMINO ACIDS CHARACTERIZEDsequence was constructed to analyze the contribution of
specific amino acids to the differing Nef-associated ki-
nase activities.
Nef immunoprecipitates prepared from transfected
CEMX174 cells were compared in in vitro kinase assays
(Fig. 2A). As previously described, SIV/17E-Fr Nef inter-
acts with a unique serine kinase resulting in the phos-
phorylation of the 35-kDa Nef protein (Fig. 2A, lane 2),
while SIV/Fr-2 Nef exhibits the typical pattern of
SIVmac239 Nef-associated kinase activity resulting in
hosphorylation of the 62-kDa (autophosphorylated Pak),
7-kDa [likely the recently identified PIX-associated p95
Brown et al., 1999)] and 35-kDa proteins by the PAK-
elated kinase and NAKC (Fig. 2A, lane 3). Substitution of
he serine at amino acid position 12 in 17E-Fr Nef with a
roline [clone S(12)P] results in the loss of all detectable
ef-associated kinase activity (Fig. 2A, lane 4). The
(12)P Nef protein is equally expressed and immunopre-
ipitated from 35S-labeled infected cells (Fig. 2B, lane 4);
owever, specific phosphorylated proteins were never
etected in kinase assays of the S(12)P Nef protein.
onversion of the lysine at amino acid 150 in SIV/17E-Fr
o a glutamic acid [clone K(150)E] enables detection of
he PAK-related kinase activity, as evidenced by the ap-
earance of phosphoprotein (pp) 62 and pp97 without
oss of pp35 (Fig. 2A, lane 5). The other amino acid
ubstitutions in SIV/17E-Fr [K(75)E, Q(93)E, and I(119)M]
FIG. 2. (A) In vitro kinase assay of Nef immunoprecipitates prepared
from CEMX174 cells transfected with infectious DNA, as described
under Materials and Methods, in the presence of 500 mCi/ml
[g-32P]ATP. A longer exposure of the E(150)K lane is shown at the far
ight. (B) SDS–PAGE separation of Nef immunoprecipitates prepared
rom [35S]methionine-labeled CEMX174 cells transfected with infectious
DNA as described under Materials and Methods. (C) In vitro kinase
assays of Nef immunoprecipitates prepared from CEMX174 cells trans-
fected with infectious DNA, as described under Materials and Meth-
ods, in the presence of 200 mM [g-32P]GTP (6000 Ci/mol). Note that the
ane locations representing clones K(150)E and E(150)K differ from
hose in (A) and (B). Results are representative of at least three inde-
endent experiments.ad no effect on the Nef-associated kinase activity (data
ot shown). Collectively, these results suggest that the
a
Cerine at amino acid 12 in SIV/17E-Fr Nef is required for
hosphorylation of pp35 (Nef) or interaction/activation of
he serine kinase associated with SIV/17E-Fr Nef, while
he glutamic acid at 150 is necessary for interaction/
ctivation of the PAK-related kinase.
To confirm the importance of these specific amino
cids to differences in Nef-associated kinase activities,
he reverse amino acid substitutions were placed in the
ackground of SIV/Fr-2, and the kinase profiles of these
oint mutants were compared. The PAK-related kinase
ctivity is conserved in the SIV/Fr-2 P(12)S clone (Fig. 2A,
ane 6), while there appears to be increased phosphor-
lation of pp35 (Fig. 2A, compare lane 6 to lane 3). We
onsistently observed this increase in phosphorylation,
uggesting that the N-terminal serine is a potential phos-
horylation site in Nef or that the P(12)S clone has
ained a new kinase association that phosphorylates
ef elsewhere. The glutamic acid to lysine substitution in
IV/Fr-2, clone E(150)K, resulted in the loss of the PAK-
elated kinase activity as assessed by the disappear-
nce of pp62 and pp97 (Fig. 2A, compare lane 7 to lane
), and to some extent, NAKC, as evidenced by de-
reased phosphorylation of pp35 (Fig. 2A, compare lane
to lane 3), which appears in longer exposures of the gel
Fig. 2A, side panel). This result confirms the importance
f the glutamic acid at amino acid 150 for PAK activation
nd suggests that PAK activation/interaction may be re-
uired for optimal association/activation with the NAKC
erine kinase that phosphorylates Nef.
The kinase that associates with SIV/17E-Fr Nef utilizes
oth ATP and GTP as phosphodonors to phosphorylate
ef (pp35), while the SIV/Fr-2 Nef-associated serine ki-
ase (NAKC) utilizes only ATP (Barber et al., 1998). To
istinguish the kinases associated with the Nef point
utants in the phosphorylation of pp35, we compared in
itro kinase assays in the presence of [g-32P]ATP or
[g-32P]GTP (Fig. 2C). Consistent with previous results,
p35 is detected in ATP-based assays of both SIV/17E-Fr
nd SIV/Fr-2 Nef proteins (Fig. 2A, lanes 2 and 3), while
p35 is only detected in GTP-based assays of the SIV/
7E-Fr Nef protein (Fig. 2C, compare lanes 2 and 3). No
hosphoproteins were associated with S(12)P Nef in the
TP-based assay (Fig. 2C, lane 4), again suggesting that
his amino acid change results in the loss of all detect-
ble SIV/17E-Fr Nef-associated kinase activity. In both
he ATP- and GTP-based assays of K(150)E Nef, pp35 is
etected (Fig. 2C, lane 7), indicating that although this
ef gains the PAK-related kinase activity, the SIV/17E-Fr
p35 kinase activity is maintained. The P(12)S Nef-asso-
iated kinase also utilizes both ATP and GTP (Fig. 2C,
ane 6), confirming that this clone gains the SIV/17E-Fr
p35 kinase activity. Like SIV/Fr-2 Nef, the E(150)K Nef-
ssociated kinase only utilizes ATP to phosphorylate
p35 (Fig. 2C, lane 5), suggesting that this Nef associ-
tes with the NAKC but not the SIV/17E-Fr pp35 kinase.
ollectively, these results indicate that the serine at
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332 BARBER ET AL.amino acid 12 in Nef is required for association/activa-
tion of the SIV/17E-Fr-specific kinase or that this serine is
the site of Nef phosphorylation by the SIV/17E-Fr-specific
kinase.
Phosphorylation of Nef is dependent on an N-terminal
serine
In our first assessment of the potential relevance of in
vitro observations of Nef-associated kinase activity to
events occurring naturally during viral infection, we pre-
viously examined the phosphorylation state of SIV/17E-Fr
and SIV/Fr-2 Nef proteins immunoprecipitated from in-
fected CEMX174 cells and macrophages derived from
rhesus macaques and reported that SIV/17E-Fr Nef but
not SIV/Fr-2 Nef (or PAK) was phosphorylated (Barber et
l., 1998). Analogously in this study, we examined the
hosphorylation states of Nef proteins immunoprecipi-
ated from [32P]orthophosphate-labeled, CEMX174 cells
transfected with infectious DNA encoding the SIV/17E-Fr
Nef mutants S(12)P and K(150)E or the SIV/Fr-2 Nef mu-
tants P(12)S and E(150)K. Consistent with our previous
findings, phosphorylated Nef is detected in lysates of
cells infected with SIV/17E-Fr, but not SIV/Fr-2 (Fig. 3,
compare lane 2 to lane 3). In fact, we have never de-
tected any of the phosphoproteins (pp62, pp97, and
pp35/Nef) routinely observed in in vitro kinase assays of
SIV/Fr-2 Nef (Fig. 2A; Barber et al., 1998; Baur et al., 1997;
awai et al., 1994). Phosphorylation of S(12)P Nef is
ndetectable even after prolonged autoradiography. Re-
iprocally, phosphorylation of P(12)S Nef was readily
etectable (Fig. 3, lane 6), confirming the requirement of
he serine at amino acid position 12 for Nef phosphory-
ation during infection. Neither the K(150)E mutation in
IV/17E-Fr Nef nor the E(150)K mutation in SIV/Fr-2 Nef
ffected the phosphorylation state of either parental Nef
rotein (Fig. 3, lanes 5 and 7).
ssociation with PAK may reduce virion-associated
ef kinase activity
An interesting characteristic of SIV/17E-Fr virions is
he incorporation of the Nef-associated kinase activity
nto the virus particle (Flaherty et al., 1997a). To deter-
FIG. 3. SDS–PAGE separation of Nef immunoprecipitates prepared
from [32P]orthophosphate-labeled CEMX174 cells transfected with in-
ectious DNA as described under Materials and Methods.ine whether this kinase activity is affected in the Nef
oint mutant virions, in vitro kinase assays of Nef immu-oprecipitates were performed on these virus particles
Fig. 4 top). Consistent with our previous observations
Flaherty et al., 1997a), virus-incorporated Nef kinase
ctivity was readily detectable in SIV/17E-Fr virions. In
ontrast, both SIV/17E-Fr S(12)P and K(150)E virions con-
ained reduced levels (and in most experiments, barely
etectable levels) of virion-incorporated, Nef-associated
inase activity; this is particularly surprising with regard
o S(12)P Nef, which exhibited no detectable kinase ac-
ivity and was not detectably phosphorylated in infected
ells. Again consistent with our previous observations,
ef-associated kinase activity was not detected in SIV/
r-2 virions (Flaherty et al., 1997a). In contrast, there was
etectable Nef-associated kinase activity isolated from
IV/Fr-2 P(12)S virions, albeit a consistently lower level
and at times undetectable) when compared to SIV/
7E-Fr virions (note that longer exposure times were
equired for adequate detection). Thus it appears that
lones Fr-2/P(12)S and 17E-Fr/K(150)E, the only clones
ontaining both PAK and 17E-Fr-associated kinase activ-
ty, exhibit reduced virion-incorporated kinase activity
ompared to SIV/17E-Fr (compare lanes 2, 5, and 6).
onversion Fr-2/E(150)K had no effect on our inability to
etect Nef-associated kinase activity in SIV/Fr-2 virions
ven after prolonged exposure of autoradiographs. Dif-
erences in kinase activity between Nef mutants are not
ttributable to differential virion incorporation of mutant
ef proteins, as immunoprecipitates of the various Nef
utants from virus produced by transfected, 35S-labeled
CEMX174 cells were not notably different (Fig. 4, bottom).
Enhanced virus infectivity is not dependent on
specific Nef-associated kinases
We and others have demonstrated that a full-length
Nef protein is required for enhanced viral infectivity
(Chowers et al., 1994; Flaherty et al., 1997a; Miller et al.,
1995; Pandori et al., 1996; Welker et al., 1996). This
ncreased infectivity may correlate with the ability of Nef
o associate with cellular kinases including the PAK-
elated kinase, NAKC, and possibly the pp35 kinase
FIG. 4. (Top) In vitro kinase assay of Nef immunoprecipitates pre-
pared from virions isolated from supernatants of CEMX174 cells trans-
fected with infectious DNA as described under Materials and Methods.
A longer exposure of the P(12)S lane is shown at the far right. (Bottom)
SDS–PAGE separation of Nef immunoprecipitates virions isolated from
supernatants of [35S]methionine-labeled CEMX174 cells transfected
with infectious DNA as described under Materials and Methods.
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333TWO SIV NEF AMINO ACIDS CHARACTERIZEDassociated with SIV/17E-Fr Nef (Baur et al., 1997; Fla-
erty et al., 1997a; Goldsmith et al., 1995; Luo et al.,
1997a). To evaluate the potential contribution of various
Nef-associated kinases to viral infectivity, we generated
a novel CEMX174/SIVLTR-luciferase indicator cell line
(LuSIV) to provide an assay system that closely resem-
bles our infection protocols. In theory, this assay is sim-
ilar to the MAGI cell assay (Chackerian, 1995) previously
utilized by us and others to examine virus infectivity
(Flaherty et al., 1997a; Luo et al., 1997a; Goldsmith et al.,
995), and the results of our novel infectivity assay are
onsistent with these previous reports in that all viruses
xpressing a full-length Nef protein are more infectious
han the SIV/17E-FrDnef virus (Fig. 5). With regard to the
utant viruses described above, viruses expressing
IVmac239 Nef [Fr-2, P(12)S, E(150)K] are, in general, less
nfectious than viruses expressing SIV/17E-Fr Nef
S(12)P, K(150)E] in this assay. The SIV/Fr-2 P(12)S virus,
hich appears to associate with PAK, NAKC, and pp35
inase in in vitro kinase assays, has slightly lower infec-
tivity than SIV/Fr-2 and E(150)K. The loss of the PAK-
related kinase activity does not appear to affect the
infectivity of the E(150)K virus. The infectivity of the
S(12)P, which has lost all detectable Nef-associated ki-
nase activity, is higher than that of SIV/17E-Fr as is the
infectivity of the K(150)E clone, which has retained the
pp35 kinase activity and gained PAK association. Similar
results were obtained when the input virus was stan-
dardized to 50 ng of p27 (data not shown). Collectively,
FIG. 5. Graphical representation of relative light units (RLU) of luci
normalized by TCID50.the results of our assay indicate that although a full-
length Nef protein is required for optimal virus infectivity,there is no correlation with specific in vitro Nef/kinase
associations.
DISCUSSION
Previous reports from this laboratory have described
the genetic and biological characteristics of a neuroviru-
lent, molecular clone, SIV/17E-Fr (Edinger et al., 1997;
Flaherty et al., 1997b; Mankowski et al., 1994, 1997). The
nef gene of SIV/17E-Fr was derived from the neuroviru-
lent strain, SIV/17E-Br, which was obtained originally by
serial passage of lymphocyte-tropic SIVmac239 in rhesus
macaques (Anderson et al., 1993). Sequence analysis of
the nef gene from brain homogenates of a rhesus ma-
caque infected with SIV/17E-Br virus (uncloned) revealed
conversion of the proline at position 12 (in SIVmac239) to
serine in nine out of nine independent PCR reactions, as
well as conversion of the glutamic acid at position 150 to
lysine in five of nine independent PCR reactions (M.T.F.
and J.E.C., unpublished data). These results support the
hypothesis that although functionally tolerable nef muta-
tions evolve rapidly during in vivo passage, which likely
enable the virus to adapt to rapid changes in intracellular
environments (i.e., cell type and activation state), muta-
tions important for continued growth in certain tissues
(i.e., the CNS) will be conserved over time. Genetic evi-
dence supporting the positive selection of nef, in vivo,
has been reported (Zanotto et al., 1999). Accordingly, the
results of PCR-based sequence analysis described
above suggest that (1) there may be selective pressure
activity produced by LuSIV cells exposed to the various viral clonesfor conversion to serine at position 12 in brain-derived
Nef in vivo and (2) a glutamic acid at position 150 may not
334 BARBER ET AL.be absolutely required for neuropathogenesis of SIV in
the CNS.
In this report, we examined the contribution of specific
amino acids that differ between the Nef proteins of SIV-
mac239 and SIV/17E-Fr. Our results identify two amino
acids in Nef, serine at position 12 and glutamic acid at
position 150 (both previously uncharacterized with re-
gard to Nef function), that mediate distinct Nef/kinase
associations. The presence of glutamic acid at position
150 is conserved without exception in SIV Nef se-
quences published in Human Retroviruses and AIDS
(Korber et al., 1998) and is essential for PAK/Nef interac-
tions, as demonstrated above by the gain of PAK activity
associated with K(150)E Nef and the reciprocal loss of
PAK activity (but not entirely NAKC activity) associated
with E(150)K Nef. As such, the E(150)K clone may well
represent the only SIV clone able to associate solely with
the serine kinase in NAKC.
We have previously reported and confirm in this study
that despite the ability of SIV/Fr-2 Nef to associate with
PAK and NAKC in cells, SIV/Fr-2 virions fail to exhibit
Nef-associated kinase activity. However, mutation of a
single amino acid, P(12)S, in SIV/Fr-2 Nef confers detect-
able virion-incorporated Nef-associated kinase activity
concomitant with the ability of P(12)S Nef to associate
with the SIV/17E-Fr-associated kinase in cells. Of inter-
est, Nef proteins with the ability to associate in cells with
both PAK and the SIV/17E-Fr-specific kinase [P(12)S,
K(150)E; Fig. 2], consistently exhibit reduced levels of
virion-incorporated Nef-associated kinase activity (Fig.
4). Because virion incorporation of Nef was not influ-
enced by the ability of Nef to associate with cellular
kinases, we offer two possible interpretations: (1) Nef
proteins complexed with PAK in the cell do not get
incorporated into progeny virions and/or (2) the kinase
activity present in cellular Nef/PAK complexes is inacti-
vated upon virion incorporation or maturation.
The N-terminal amino acids of Nef direct Nef myris-
toylation and, if expanded to include amino acid 22,
suffice for association with the unidentified serine kinase
present in NAKC (Baur et al., 1997). The data presented
herein extend the functionality of this region in that we
demonstrate that the serine at position 12 in SIV/17E-Fr
Nef is required both for detection of Nef-associated ki-
nase activity in vitro and for Nef phosphorylation in in-
fected cells. We have previously shown that the kinase
associated with SIV/17E-Fr Nef is distinct from the PAK-
related kinase and the unidentified serine kinase in
NAKC, due to its unique ability to utilize both ATP and
GTP as phosphodonors (Barber et al., 1998). However,
we were previously unable to determine definitively if
SIV/17E-Fr Nef also associated with the unidentified
serine kinase in NAKC. Based on two observations from
the data presented above, we are now confident that
SIV/17E-Fr Nef does not associate with the unidentified
serine kinase in NAKC. First, because the PAK-relatedkinase does not phosphorylate Nef (Sawai et al., 1994),
we can conclude that the unidentified serine kinase in
NAKC, which does phosphorylate Nef, does not require a
serine at position 12 because SIV/Fr-2 Nef (expressing a
proline at position 12) is phosphorylated in in vitro kinase
assays (Barber et al., 1998). Hence, we would expect to
see phosphorylated S(12)P Nef in in vitro kinase assays
if NAKC was able to associate with SIV/17E-Fr Nef. Sec-
ond, we always observe a modest increase in the phos-
phorylation of K(150)E Nef (pp35) in ATP-based in vitro
kinase assays of K(150)E Nef with no concomitant loss of
GTP-dependent activity (Fig. 2). Since no potential phos-
phorylation site is provided by the K to E mutation, it
seems likely that the mutation enables association with
PAK/NAKC.
The relevance of Nef/PAK/NAKC associations to Nef
phosphorylation during infection in vitro, as potentially
related to Nef function(s) during infection in vivo, remains
confounding. We have reported previously and present
data again here that fail to detect phosphorylated SIV/
Fr-2 Nef or PAK in Nef immunoprecipitates from
[32P]orthophosphate-labeled SIV/Fr-2-infected cell ly-
sates, whereas cell lysates from parallel SIV/17E-Fr in-
fections contain readily detectable phosphorylated Nef
(Fig. 3). Further, mutation of serine 12 abolishes detect-
able SIV/17E-Fr Nef phosphorylation, an observation
consistent with a previous report which demonstrates
that 17E-Fr Nef is phosphorylated on serine (Barber et
al., 1998). The effect of phosphorylation on Nef func-
tion(s) is yet undetermined. Conceivably, phosphoryla-
tion of a myristoylated protein may disrupt membrane
association, as has been described for both the MARCKS
protein and src (reviewed in McLaughlin and Aderem,
1995). Myristoylation of proteins is not sufficient for mem-
brane association, which also requires the presence of
exposed basic amino acids to bind acidic phospholipids
(McLaughlin and Aderem, 1995). Phosphorylation within
the basic cluster can neutralize the association with
acidic phospholipids enabling translocation to the cy-
tosol. There are six basic amino acids surrounding (;17
amino acids) serine 12 in SIVmac239 and SIV/17EFr Nef
proteins, and we are currently evaluating potential differ-
ences in the cellular distribution of the mutant Nef pro-
teins.
The ability to detect kinase activity associated with
S(12)P Nef derived from virions constitutes the most
intriguing observation of this study as this Nef protein is
not detectably phosphorylated and fails to associate with
kinase activity in cells. It is tempting to speculate that the
serine at position 12 is the preferred site of phosphory-
lation by the kinase and that phosphorylation of SIV/17E-
Fr- Nef in virions is so vital for SIV/17E-Fr Nef function (as
constricted by the other four mutations) that an alterna-
tive phosphorylation site (such as serine at position 13)
is utilized under the mutational pressure of S(12)P. Sim-
ilar sequence flexibilities (i.e., SXXD/E or SXD/E) have
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II (Hardie and Hanks, 1995).
To evaluate the contribution of Nef-associated kinases
to enhancement of virion infectivity, virions representing
our panel of Nef point mutants were compared in our
novel infectivity assay. The results presented in Fig. 5
show no correlation of particular kinase association with
infectivity. In general, SIV/17E-Fr or viruses expressing
point mutations in the background of SIV/17E-Fr were
more infectious than SIV/Fr-2-based virions. Analyses of
the infectivities of the point mutants that did not affect
Nef-kinase associations (data not shown) indicated that
construction of viruses expressing various combinations
of Nef point mutations may be needed to elucidate the
basis for increased infectivity of SIV/17E-Fr based viri-
ons. As such, we conclude for the SIV/17E-Fr-associated
kinase and corroborate the conclusions of independent
reports pertaining to other Nef-associated kinases (Luo
et al., 1997b; Tokunaga et al., 1999) that although the
ability of Nef to associate with cellular kinases may be a
conserved feature of Nef, associations between 17E-Fr
Nef/unidentified serine kinase and Fr-2 Nef/PAK/NAKC
do not translate directly to Nef-mediated enhancement of
viral infectivity.
MATERIALS AND METHODS
Cells
CEMX174 cells were obtained from AIDS Research
and Reagent Program and maintained in RPMI 1640
(Cellgro, VA) supplemented with 10% FBS, 2 mM sodium
pyruvate (Sigma, St. Louis, MO), 10 mM HEPES (Life
Technologies, Gaithersburg, MD), 0.5 mg/ml gentamicin
(Life Technologies), 2 mM glutamine (Life Technologies);
(cRPMI).
Construction of Nef point mutants
The construction of the infectious molecular clones
SIV/17E-Fr and SIV/Fr-2 was described previously (Fla-
herty et al., 1997b). These clones were used for the
construction of the Nef point mutants described here.
SIV/17E-Fr contains the nef gene from the neuroviru-
lent virus SIV/17E-Br, while SIV/Fr-2 contains the
SIVmac239 nef gene. These two viruses are identical ex-
cept for the five amino acid coding differences between
the two Nef proteins (Fig. 1). To construct the Nef point
mutants, the NheI BpuI102I fragments from SIV/17E-Fr or
SIV/Fr-2 were amplified by PCR using overlapping prim-
ers to mutate the following amino acids in SIV/17E-Fr Nef
to the SIV/Fr-2 Nef sequence: K(75)E, Q(93)E, I(119)M,
and K(150)E. In SIV/Fr-2 Nef, the E(150)K mutation was
made. These sequence modifications do not alter the
amino acid sequence of the overlapping transmembrane
region of the envelope. The PCR products were digested
with SalI and inserted into SalI-digested pLG338/IBI-30.The desired mutation and the sequence of the PCR
products were confirmed by DNA sequence analysis.
The subclones were digested with NheI and BpuI102I,
and the fragments were inserted into SIV/17E-Fr or SIV/
Fr-2 to construct full-length molecular clones with the
desired amino acid changes.
To construct SIV/17E-Fr S(12)P and SIV/Fr-2 P(12)S, the
pLG338/IBI-30 NheI–BpuI102I subclones, pLG-17E-Fr
and pLG-Fr-2 (Flaherty et al., 1997b) were digested with
NcoI and NsiI (amino acids 69–197 in Nef). The purified
restriction fragments were swapped between the two
clones, resulting in subclones pLG-17E-Fr S(12)P and
pLG-Fr-2 P(12)S. The desired mutation and the sequence
of the subclones were confirmed by DNA sequence
analysis. The subclones were digested with NheI and
BpuI102I, and the fragments were inserted into SIV/
17E-Fr or SIV/Fr-2 to construct full-length molecular
clones with the single amino acid change.
Transfection and preparation of virus stocks
CEMX174 cells were transfected with 10–12 mg of
infectious DNA by electroporation as described previ-
ously (Flaherty et al., 1997a). Cell culture supernatants
containing virus were clarified by centrifugation at 1200 g
for 10 min, filtered through a 0.45-mm-pore-size mem-
brane, and quantitated for p27 content, reverse transcrip-
tase activity, and TCID50 (Flaherty et al., 1997a). Virus
stocks were stored at 280°C.
Immunoprecipitation and kinase assays
Immunoprecipitations and kinase assays were per-
formed as described previously (Barber et al., 1998; Fla-
herty et al., 1997a). Briefly, transfected CEMX174 cells
were collected by low-speed centrifugation, washed
once in PBS, and lysed in 300–500 ml lysis buffer con-
aining 0.5% (vol/vol) Nonidet-P40, 2 mM EDTA, 137 mM
aCl, 50 mM Tris–HCl (pH 8.0), 10% (vol/vol) glycerol
upplemented with protease inhibitors (1 mg/ml leupep-
in; 1 mg/ml aprotinin).
Cell culture supernatants containing virus were quan-
itated by RT assays and clarified twice by centrifugation
t 1200 g for 10 min. The clarified supernatants were
iltered through a 0.45-mm-pore-size membrane and con-
centrated by centrifugation through a 20% (w/vol) su-
crose cushion in TNE [25 mM Tris–HCl (pH 8.0), 150 mM
NaCl, 2 mM EDTA] at 125,000 g for 1 h at 4°C. The virion
pellets were lysed in 300 ml lysis buffer (above).
Cell and virion lysates were precleared by incubation
with normal rabbit serum for 1 h at 4°C followed by
incubation with Protein A–Sepharose 4 Fast Flow (Phar-
macia) for 1 h at 4°C. The precleared lysates were
incubated with 10 ml of Nef antisera for 1.5 h at 4°C
followed by incubation with Protein A–Sepharose for
1.5 h at 4°C. The immunoprecipitates were washed 3
times with lysis buffer, once with kinase buffer [50 mM
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336 BARBER ET AL.Tris–HCl (pH 8.0), 10 mM NaCl, 1% Triton X-100, 5 mM
MgCl2, 5 mM MnCl2, 2 mM sodium orthovanadate], re-
uspended in kinase reaction buffer [kinase buffer con-
aining 500 mCi/ml [g -32P]ATP or 200 mM [g -32P]GTP (6000
Ci/mol), ICN Radiochemicals Inc., Irvine, CA], and incu-
bated for 10–12 min at room temperature. The immuno-
precipitates were washed with ice-cold lysis buffer and
the proteins were analyzed by SDS–PAGE.
Metabolic labeling
CEMX174 cells were tranfected as described above.
Seven to 10 days posttransfection cells were prepared
for metabolic labeling. For 35S-labeling, cells were incu-
ated in methionine-free RPMI (Life Technologies) con-
aining 2% FBS and 2 mM glutamine for 1 h before
ddition of 100 mCi/ml 35S-TransLabel (ICN Radiochemi-
cals Inc.) for 18 h. For 32P-labeling, cells were incubated
in phosphate-free RPMI (Life Technologies) containing
10% dialyzed FBS (Life Technologies) and 2 mM glu-
tamine for 1 h before addition of [32P]orthophosphate
(NEN Life Science Products, Boston, MA) for 18 h. La-
beled cells and cell culture supernatants were harvested
as described above.
Construction of the LuSIV reporter cells
The LuSIV reporter cells were constructed using the
cell line CEMX174 (permissive for most strains of SIV)
and a reporter construct pLuc. The pLuc construct was
made by the insertion of the SIVmac239 (2225 to 1149)
long terminal repeat (LTR) upstream of the firefly lucif-
erase reporter gene (obtained in the plasmid pGL3 from
Promega, Madison, WI) in the background of the pCEP4
plasmid (Invitrogen, Carlsbad CA).
To generate the LuSIV cells, CEMX174 cells (5 3 105)
ere transfected by electroporation with 12 mg of pLuc
lasmid DNA using a Bio-Rad gene pulser (Bio-Rad,
ichmond, CA). The cells were cultured in cRPMI sup-
lemented with 1 mg/ml hygromycin B to select for sta-
le transfectants. Once a stable cell line was obtained,
he hygromycin B concentration was lowered to 300
mg/ml for maintenance of the pLuc plasmid. The charac-
terization of these cells is reported elsewhere (Roos et
al., 2000).
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